Global Cord Blood (NYSE:CO) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a research report report published on Wednesday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

CO stock opened at $1.25 on Wednesday. The stock’s fifty day moving average is $1.58 and its two-hundred day moving average is $1.40. The stock has a market capitalization of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.